Imine reductase

Last updated
SkIRED
Streptomyces kanamyceticus imine reductase PDB 3ZHB.png
Streptomyces kanamyceticusR-selective imine reductase PDB: 3ZHB
Identifiers
EC no. 1.5.1.48
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / QuickGO
Search
PMC articles
PubMed articles
NCBI proteins

An imine reductase (IRED) is an enzyme that reduces imines to amines. [1] [2] This family of enzymes is employed in the industrial production of amine-containing pharmaceuticals. [3] The IRED enzymes that are found to catalyze both imine formation and imine reduction are called reductive aminases (RedAms).

Contents

Function

Imine reduction

IREDs were originally discovered in 2010 by screening bacterial strains for reducing activity on 2-methyl-1-pyrroline (2-MPN). [4] [5] Based on each member's ability to reduce 2-MPN to (R)- or (S)-2-methylpyrrolidine they are designated as R-selective or S-selective, respectively. [6] [7]

Reductive amination

IREDs have been employed to reduce imines formed from ketone-amine mixtures. [1] [2] The conversion is not a genuine reductive amination as only the second half of the two-part reaction is catalyzed. In 2017 an IRED was discovered that catalyzed both steps of reductive amination of a wide scope of ketone-amine pairs. [8] These are dubbed reductive aminases (RedAms). [1] [2] Engineered RedAms have been employed in industrial processes to support production of pharmaceuticals for clinical trials and commercial manufacturing. [9] [10]

Structure

IREDs are dimeric enzymes with each protomer having an N-terminal Rossmann nucleotide-binding domain and a C-terminal dimerization domain joined by a long interdomain α-helix. [3] [11] Each protomer's α-helical dimerization domain wraps around the interdomain helix of its dimer partner forming the substrate-binding cleft above the NAD(P)H cofactor binding site in the Rossmann domain. 3-Hydroxybutyrate dehydrogenases have similar N-terminal nucleotide-binding and C-terminal dimerization domains, but do not share the extensive dimerization interface of IREDs. [12]

See also

Related Research Articles

<span class="mw-page-title-main">Imine</span> Organic compound or functional group containing a C=N bond

In organic chemistry, an imine is a functional group or organic compound containing a carbon–nitrogen double bond. The nitrogen atom can be attached to a hydrogen or an organic group (R). The carbon atom has two additional single bonds. Imines are common in synthetic and naturally occurring compounds and they participate in many reactions.

Amination is the process by which an amine group is introduced into an organic molecule. This type of reaction is important because organonitrogen compounds are pervasive.

<span class="mw-page-title-main">Flavin adenine dinucleotide</span> Redox-active coenzyme

In biochemistry, flavin adenine dinucleotide (FAD) is a redox-active coenzyme associated with various proteins, which is involved with several enzymatic reactions in metabolism. A flavoprotein is a protein that contains a flavin group, which may be in the form of FAD or flavin mononucleotide (FMN). Many flavoproteins are known: components of the succinate dehydrogenase complex, α-ketoglutarate dehydrogenase, and a component of the pyruvate dehydrogenase complex.

Reductive amination is a form of amination that involves the conversion of a carbonyl group to an amine via an intermediate imine. The carbonyl group is most commonly a ketone or an aldehyde. It is a common method to make amines and is widely used in green chemistry since it can be done catalytically in one-pot under mild conditions. In biochemistry, dehydrogenase enzymes use reductive amination to produce the amino acid, glutamate. Additionally, there is ongoing research on alternative synthesis mechanisms with various metal catalysts which allow the reaction to be less energy taxing, and require milder reaction conditions. Investigation into biocatalysts, such as imine reductases, have allowed for higher selectivity in the reduction of chiral amines which is an important factor in pharmaceutical synthesis.

<span class="mw-page-title-main">Biocatalysis</span> Use of natural catalysts to perform chemical transformations

Biocatalysis refers to the use of living (biological) systems or their parts to speed up (catalyze) chemical reactions. In biocatalytic processes, natural catalysts, such as enzymes, perform chemical transformations on organic compounds. Both enzymes that have been more or less isolated and enzymes still residing inside living cells are employed for this task. Modern biotechnology, specifically directed evolution, has made the production of modified or non-natural enzymes possible. This has enabled the development of enzymes that can catalyze novel small molecule transformations that may be difficult or impossible using classical synthetic organic chemistry. Utilizing natural or modified enzymes to perform organic synthesis is termed chemoenzymatic synthesis; the reactions performed by the enzyme are classified as chemoenzymatic reactions.

<span class="mw-page-title-main">Glutathione reductase</span> Enzyme

Glutathione reductase (GR) also known as glutathione-disulfide reductase (GSR) is an enzyme that in humans is encoded by the GSR gene. Glutathione reductase catalyzes the reduction of glutathione disulfide (GSSG) to the sulfhydryl form glutathione (GSH), which is a critical molecule in resisting oxidative stress and maintaining the reducing environment of the cell. Glutathione reductase functions as dimeric disulfide oxidoreductase and utilizes an FAD prosthetic group and NADPH to reduce one molar equivalent of GSSG to two molar equivalents of GSH:

<span class="mw-page-title-main">Sodium cyanoborohydride</span> Chemical compound

Sodium cyanoborohydride is a chemical compound with the formula Na[BH3(CN)]. It is a colourless salt used in organic synthesis for chemical reduction including that of imines and carbonyls. Sodium cyanoborohydride is a milder reductant than other conventional reducing agents.

<span class="mw-page-title-main">Benzylamine</span> Chemical compound

Benzylamine is an organic chemical compound with the condensed structural formula C6H5CH2NH2 (sometimes abbreviated as PhCH2NH2 or BnNH2). It consists of a benzyl group, C6H5CH2, attached to an amine functional group, NH2. This colorless water-soluble liquid is a common precursor in organic chemistry and used in the industrial production of many pharmaceuticals. The hydrochloride salt was used to treat motion sickness on the Mercury-Atlas 6 mission in which NASA astronaut John Glenn became the first American to orbit the Earth.

In organic chemistry, the Buchwald–Hartwig amination is a chemical reaction for the synthesis of carbon–nitrogen bonds via the palladium-catalyzed coupling reactions of amines with aryl halides. Although Pd-catalyzed C–N couplings were reported as early as 1983, Stephen L. Buchwald and John F. Hartwig have been credited, whose publications between 1994 and the late 2000s established the scope of the transformation. The reaction's synthetic utility stems primarily from the shortcomings of typical methods for the synthesis of aromatic C−N bonds, with most methods suffering from limited substrate scope and functional group tolerance. The development of the Buchwald–Hartwig reaction allowed for the facile synthesis of aryl amines, replacing to an extent harsher methods while significantly expanding the repertoire of possible C−N bond formations.

<span class="mw-page-title-main">Sorbitol dehydrogenase</span> Enzyme

Sorbitol dehydrogenase is a cytosolic enzyme. In humans this protein is encoded by the SORD gene.

<span class="mw-page-title-main">1-Pyrroline-5-carboxylic acid</span> Chemical compound

1-Pyrroline-5-carboxylic acid is a cyclic imino acid. Its conjugate base and anion is 1-pyrroline-5-carboxylate (P5C). In solution, P5C is in spontaneous equilibrium with glutamate-5-semialdhyde (GSA).

<span class="mw-page-title-main">Glycerate dehydrogenase</span>

In enzymology, a glycerate dehydrogenase (EC 1.1.1.29) is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">12-oxophytodienoate reductase</span> Class of enzymes

12-oxophytodienoate reductase (OPRs) is an enzyme of the family of Old Yellow Enzymes (OYE). OPRs are grouped into two groups: OPRI and OPRII – the second group is the focus of this article, as the function of the first group is unknown, but is the subject of current research. The OPR enzyme utilizes the cofactor flavin mononucleotide (FMN) and catalyzes the following reaction in the jasmonic acid synthesis pathway:

<span class="mw-page-title-main">NAD(P)H dehydrogenase (quinone)</span>

In enzymology, a NAD(P)H dehydrogenase (quinone) (EC 1.6.5.2) is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">Pyrroline-5-carboxylate reductase</span>

In enzymology, a pyrroline-5-carboxylate reductase (EC 1.5.1.2) is an enzyme that catalyzes the chemical reaction

<span class="mw-page-title-main">PYCR1</span> Protein-coding gene in the species Homo sapiens

Pyrroline-5-carboxylate reductase 1, mitochondrial is an enzyme that in humans is encoded by the PYCR1 gene.

<span class="mw-page-title-main">Aldehyde dehydrogenase 18 family, member A1</span> Protein-coding gene in the species Homo sapiens

Delta-1-pyrroline-5-carboxylate synthetase (P5CS) is an enzyme that in humans is encoded by the ALDH18A1 gene. This gene is a member of the aldehyde dehydrogenase family and encodes a bifunctional ATP- and NADPH-dependent mitochondrial enzyme with both gamma-glutamyl kinase and gamma-glutamyl phosphate reductase activities. The encoded protein catalyzes the reduction of glutamate to delta1-pyrroline-5-carboxylate, a critical step in the de novo biosynthesis of proline, ornithine and arginine. Mutations in this gene lead to hyperammonemia, hypoornithinemia, hypocitrullinemia, hypoargininemia and hypoprolinemia and may be associated with neurodegeneration, cataracts and connective tissue diseases. Alternatively spliced transcript variants, encoding different isoforms, have been described for this gene. As reported by Bruno Reversade and colleagues, ALDH18A1 deficiency or dominant-negative mutations in P5CS in humans causes a progeroid disease known as De Barsy Syndrome.

Electrophilic amination is a chemical process involving the formation of a carbon–nitrogen bond through the reaction of a nucleophilic carbanion with an electrophilic source of nitrogen.

<span class="mw-page-title-main">Hydrogen auto-transfer</span>

Hydrogen auto-transfer, also known as borrowing hydrogen, is the activation of a chemical reaction by temporary transfer of two hydrogen atoms from the reactant to a catalyst and return of those hydrogen atoms back to a reaction intermediate to form the final product. Two major classes of borrowing hydrogen reactions exist: (a) those that result in hydroxyl substitution, and (b) those that result in carbonyl addition. In the former case, alcohol dehydrogenation generates a transient carbonyl compound that is subject to condensation followed by the return of hydrogen. In the latter case, alcohol dehydrogenation is followed by reductive generation of a nucleophile, which triggers carbonyl addition. As borrowing hydrogen processes avoid manipulations otherwise required for discrete alcohol oxidation and the use of stoichiometric organometallic reagents, they typically display high levels of atom-economy and, hence, are viewed as examples of Green chemistry.

Morphinone reductase is an enzyme which catalyzes the NADH-dependent saturation of the carbon-carbon double bond of morphinone and codeinone, yielding hydromorphone and hydrocodone respectively. This saturation reaction is assisted by a FMN cofactor and the enzyme is a member of the α/β-barrel flavoprotein family. The sequence of the enzyme has been obtained from bacteria Pseudomonas putida M10 and has been successfully expressed in yeast and other bacterial species. The enzyme is reported to harbor high sequence and structural similarity to the Old Yellow Enzyme, a large group of flavin-dependent redox biocatalysts of yeast species, and an oestrogen-binding protein of Candida albicans. The enzyme has demonstrated value in biosynthesis of semi-opiate drugs in microorganisms, expanding the chemical diversity of BIA biosynthesis.

References

  1. 1 2 3 Mangas-Sanchez, Juan; France, Scott P; Montgomery, Sarah L; Aleku, Godwin A; Man, Henry; Sharma, Mahima; Ramsden, Jeremy I; Grogan, Gideon; Turner, Nicholas J (2017). "Imine reductases (IREDs)". Current Opinion in Chemical Biology. 37: 19–25. doi:10.1016/j.cbpa.2016.11.022. PMID   28038349.
  2. 1 2 3 Lenz, Maike; Borlinghaus, Niels; Weinmann, Leonie; Nestl, Bettina M. (2017). "Recent advances in imine reductase-catalyzed reactions". World Journal of Microbiology and Biotechnology. 33 (11): 199. doi:10.1007/s11274-017-2365-8. ISSN   0959-3993. PMID   29022156. S2CID   255141416.
  3. 1 2 Gilio, Amelia K.; Thorpe, Thomas W.; Turner, Nicholas; Grogan, Gideon (2022). "Reductive aminations by imine reductases: from milligrams to tons". Chemical Science. 13 (17): 4697–4713. doi:10.1039/D2SC00124A. ISSN   2041-6520. PMC   9067572 . PMID   35655886.
  4. Mitsukura, Koichi; Suzuki, Mai; Tada, Kazuhiro; Yoshida, Toyokazu; Nagasawa, Toru (2010-08-12). "Asymmetric synthesis of chiral cyclic amine from cyclic imine by bacterial whole-cell catalyst of enantioselective imine reductase". Organic & Biomolecular Chemistry. 8 (20): 4533–4535. doi:10.1039/C0OB00353K. ISSN   1477-0520. PMID   20820664.
  5. Mitsukura, Koichi; Suzuki, Mai; Shinoda, Sho; Kuramoto, Tatsuya; Yoshida, Toyokazu; Nagasawa, Toru (2011-09-23). "Purification and Characterization of a Novel ( R )-Imine Reductase from Streptomyces sp. GF3587". Bioscience, Biotechnology, and Biochemistry. 75 (9): 1778–1782. doi:10.1271/bbb.110303. ISSN   0916-8451. PMID   21897027.
  6. Scheller, Philipp N.; Fademrecht, Silvia; Hofelzer, Sebastian; Pleiss, Jürgen; Leipold, Friedemann; Turner, Nicholas J.; Nestl, Bettina M.; Hauer, Bernhard (2014-10-13). "Enzyme Toolbox: Novel Enantiocomplementary Imine Reductases". ChemBioChem. 15 (15): 2201–2204. doi:10.1002/cbic.201402213. ISSN   1439-4227. PMID   25163890. S2CID   42316871.
  7. Fademrecht, Silvia; Scheller, Philipp N.; Nestl, Bettina M.; Hauer, Bernhard; Pleiss, Jürgen (2016). "Identification of imine reductase-specific sequence motifs". Proteins: Structure, Function, and Bioinformatics. 84 (5): 600–610. doi:10.1002/prot.25008. ISSN   0887-3585. PMID   26857686. S2CID   10149699.
  8. Aleku, Godwin A.; France, Scott P.; Man, Henry; Mangas-Sanchez, Juan; Montgomery, Sarah L.; Sharma, Mahima; Leipold, Friedemann; Hussain, Shahed; Grogan, Gideon; Turner, Nicholas J. (2017). "A reductive aminase from Aspergillus oryzae". Nature Chemistry. 9 (10): 961–969. Bibcode:2017NatCh...9..961A. doi:10.1038/nchem.2782. ISSN   1755-4330. PMID   28937665. S2CID   33498137.
  9. Schober, Markus; MacDermaid, Chris; Ollis, Anne A.; Chang, Sandy; Khan, Diluar; Hosford, Joseph; Latham, Jonathan; Ihnken, Leigh Anne F.; Brown, Murray J. B.; Fuerst, Douglas; Sanganee, Mahesh J.; Roiban, Gheorghe-Doru (2019-09-16). "Chiral synthesis of LSD1 inhibitor GSK2879552 enabled by directed evolution of an imine reductase". Nature Catalysis. 2 (10): 909–915. doi:10.1038/s41929-019-0341-4. ISSN   2520-1158. S2CID   202580808.
  10. Kumar, Rajesh; Karmilowicz, Michael J.; Burke, Dylan; Burns, Michael P.; Clark, Leslie A.; Connor, Christina G.; Cordi, Eric; Do, Nga M.; Doyle, Kevin M.; Hoagland, Steve; Lewis, Chad A.; Mangan, David; Martinez, Carlos A.; McInturff, Emma L.; Meldrum, Kevin (2021-09-21). "Biocatalytic reductive amination from discovery to commercial manufacturing applied to abrocitinib JAK1 inhibitor". Nature Catalysis. 4 (9): 775–782. doi:10.1038/s41929-021-00671-5. ISSN   2520-1158. S2CID   237588372.
  11. Rodríguez-Mata, María; Frank, Annika; Wells, Elizabeth; Leipold, Friedemann; Turner, Nicholas J.; Hart, Sam; Turkenburg, Johan P.; Grogan, Gideon (2013-07-22). "Structure and Activity of NADPH-Dependent Reductase Q1EQE0 from Streptomyces kanamyceticus , which Catalyses the R -Selective Reduction of an Imine Substrate". ChemBioChem. 14 (11): 1372–1379. doi:10.1002/cbic.201300321. ISSN   1439-4227. PMID   23813853. S2CID   205557837.
  12. Lenz, Maike; Fademrecht, Silvia; Sharma, Mahima; Pleiss, Jürgen; Grogan, Gideon; Nestl, Bettina M (2018-04-01). "New imine-reducing enzymes from β -hydroxyacid dehydrogenases by single amino acid substitutions". Protein Engineering, Design and Selection. 31 (4): 109–120. doi:10.1093/protein/gzy006. ISSN   1741-0126. PMID   29733377.